Howard Hughes Holdings Inc
For the period ended Dec 31, 2023. Filed Feb 27, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 27, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Income (Loss)
| FINANCIAL STATEMENTS | Table of ContentsIndex to Financial Statements |
|---|
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
| Year Ended December 31, | |||
|---|---|---|---|
| thousands | 2023 | 2022 | 2021 |
| Net income (loss) | $(551,530) | $184,636 | $48,924 |
| Other comprehensive income (loss) | |||
| Interest rate caps and swaps (a) | (9,322) | 31,698 | 17,960 |
| Pension adjustment (b) | 259 | (183) | 452 |
| Reclassification of the Company's share of previously deferred derivative gains to net income (c) | — | (6,723) | — |
| Share of investee's other comprehensive income (d) | — | — | 5,721 |
| Other comprehensive income (loss) | (9,063) | 24,792 | 24,133 |
| Comprehensive income (loss) | (560,593) | 209,428 | 73,057 |
| Comprehensive (income) loss attributable to noncontrolling interests | (243) | (103) | 7,176 |
| Comprehensive income (loss) attributable to common stockholders | $(560,836) | $209,325 | $80,233 |
(a)Amounts are shown net of deferred tax benefit of $2.7 million for the year ended December 31, 2023, deferred tax expense of $9.5 million for the year ended December 31, 2022, and deferred tax expense of $5.1 million for the year ended December 31, 2021.
(b)The deferred tax impact was not meaningful for the years ended December 31, 2023, 2022, and 2021.
(c)In March 2022, the Company completed the sale of its ownership interest in 110 North Wacker and released a net of $6.7 million from Accumulated other comprehensive income (loss), representing the Company’s $8.6 million share of previously deferred gains associated with the Venture’s derivative instruments net of tax expense of $1.9 million. See Note 2 -Investments in Unconsolidated Ventures for additional information.
(d)Amount is shown net of deferred tax expense of $1.6 million for the year ended December 31, 2021.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.